The RDPLF provides to every new patient an informative note explaining the use made of their data, and a consent form that must be signed. This note does not include a mention to full free access to the data on the Internet, but explains that the data will be made available to researchers in the field of PD. Therefore, data are kept by the RDPLF, and researchers in the field of PD can access them by submitting a query with a research protocol. No co-authorship is required to gain access to the data set of this study, neither to any other data from the RDPLF. The RDPLF keeps archives of the dataset analyzed for this study. The person to contact for access to the dataset is Pr Max Dratwa, vice president of the RDPLF, through <max.dratwa@chu-brugmann.be>.

Introduction {#sec005}
============

One of the main challenges of peritoneal dialysis (PD) is to ensure the sustainability of the technique. Peritonitis is a leading cause of technique failure \[[@pone.0218677.ref001]\], \[[@pone.0218677.ref002]\], \[[@pone.0218677.ref003]\]. Individual risks factors for technique failure and peritonitis have been identified \[[@pone.0218677.ref004]\], \[[@pone.0218677.ref005]\], \[[@pone.0218677.ref006]\]. It has been demonstrated that a center effect explained by center characteristics influences the risks of peritonitis and technique failure \[[@pone.0218677.ref007]\], \[[@pone.0218677.ref008]\], \[[@pone.0218677.ref009]\]. This is a matter of concern since center characteristics are modifiable. PD practices are heterogeneous and variations observed between PD units contribute to the risk of peritonitis \[[@pone.0218677.ref010]\], \[[@pone.0218677.ref011]\], \[[@pone.0218677.ref012]\]. Consequently quality improvement programs at the center level are necessary \[[@pone.0218677.ref007]\], \[[@pone.0218677.ref013]\]. Identifying groups of centers with higher risks of peritonitis or technique failure is of importance if one wants to prioritize the action at the nationwide level. Furthermore practices may be interrelated and influence the patient outcomes.

We identified clusters of French PD centers that were grouped according to the proximity of their PD catheter related practices \[[@pone.0218677.ref010]\]. We hypothesize that these patterns of practices identified by a hierarchical analysis, may affect the patient outcome on PD. The objective of this study was to determine whether those clusters of centers with similar practices are associated with the risks of technique failure, peritonitis, and technique failure due to peritonitis.

Materials and methods {#sec006}
=====================

Study population {#sec007}
----------------

This was a retrospective study using data from the \"catheter\" section of the French Language Peritoneal Dialysis Registry (RDPLF) \[[@pone.0218677.ref014]\]. Eighty-seven centers provide data for the optional catheter section. Centers where fewer than 5 catheters were registered, and centers located in French overseas territories were excluded. Patients older than 18 years starting PD in France between 1 January 2012 and 31 December 2016 were included in the study. The end of study period was 3 February 2017.

Definition of variables {#sec008}
-----------------------

### Individual characteristics (level 1 covariates) {#sec009}

Age, sex, weight, obesity (defined as a body mass index greater than 30 kg/m^2^), malnutrition (defined as a composite of BMI \< 18.5 kg/m2 or \< 21 kg/m2 for subjects older than 70 years old, and hypoalbuminemia, according to the pathology), causal nephropathy, existence of diabetes and its type of treatment, and modified Charlson comorbidity index, which is the Charlson comorbidity index after excluding the age subscore, were extracted from the registry.

### Center practices and clusters of centers (level 2 covariates) {#sec010}

Type of PD catheter, surgery technique, administration of antibiotic prophylaxis prior to catheter insertion, specialized surgeon for catheter placement, screening for nasal carriage of *S*. *aureus*, use of prophylactic nasal antistaphylococcal cream, use of local antistaphylococcal cream or ointment on the catheter emerging site, delay after catheter insertion for first dressing, type of antiseptic for dressing refection, PD modality 3 months after dialysis initiation (automated peritoneal dialysis \[APD\] or continuous ambulatory peritoneal dialysis \[CAPD\]), assistance for PD (self-PD, family assistance, nurse assistance), type of administrative structure, and center size (number of catheters registered) were obtained from the database.

For each center, a practice was defined as being the center standard practice during the follow-up period whenever it was applied in 75% or more of the listed cases, from the individual data available in the registry.

A hierarchical clustering analysis using Ward's method was applied to determine five clusters of centers with similar practices \[[@pone.0218677.ref015]\]. Each practice is thought of as a specific dimension of a virtual space, and the different modalities of the practice constitute the gradations along this dimension. A space of practices is therefore built, in which each center has a location according to its practices ([S1 Fig](#pone.0218677.s004){ref-type="supplementary-material"}). A Euclidian distance is defined in this virtual space and computed between the centers. Then, a dendrogram is built, joining centers with nodes at height proportional to the proximity of their practices. This allows the constitution of clusters of centers with similar practices. The number of clusters is determined graphically according to the semi-partial R-squared graph, to optimize the variability between clusters while minimizing complexity.

Study outcomes {#sec011}
--------------

The primary outcome was PD technique failure, defined as a transfer to hemodialysis for longer than 2 months. Two events of interest were considered as secondary outcomes: first peritonitis episode for a given PD catheter, and technique failure due to peritonitis. A supplemental analysis was performed computing the risks for early or late technique failure (occurring respectively earlier or later than 3 months after the starting of PD). A composite outcome of technique failure and mortality was assessed to identify covariates potentially decreasing the risk of technique failure while increasing mortality.

Statistical analysis {#sec012}
--------------------

Categorical variables were described by their frequencies and percentages and continuous variables by their median and interquartile ranges. Differences of the distribution of practices among the clusters were evaluated using chi-squared tests. We examined for collinearity by assessing the generalized variance inflation factor.

Survival analysis {#sec013}
-----------------

### Cox modeling {#sec014}

Kaplan-Meier survival curves were drawn, and log-rank tests were performed to determine whether the outcomes were different between the five clusters. Cox models were used to explore the association between the covariates and the events of interest: technique failure, first peritonitis episode, early and late technique failure. Considering the event technique failure due to peritonitis, other causes of technique failure would have been censored in a classical Cox model, overestimating the HR, so this event was not considered in the Cox model. Cause-specific HR with 95% confidence intervals (CI) were estimated. Regression splines were used to explore the effect of continuous variables and to choose their management in the models. Proportional hazard assumption was tested by visual inspection of Schoenfeld residual plots. Covariates were entered in the multivariate analysis when p \< 0.20 in the bivariate analysis, the cluster covariate was entered a priori since it was the covariate of interest.

### Fine and Gray modeling {#sec015}

To avoid overestimating hazard rate, a competing risk analysis was performed, accounting for the risk of death, renal transplantation and other causes of technique failure \[[@pone.0218677.ref016]\]. The Fine and Gray model allows the estimation of the subdistribution HR, which is defined as the hazard of the event of interest in the presence of a competing event. The Fine and Gray modeling was used to explore the association between the covariates and all the outcomes of interest.

### Hierarchical analysis {#sec016}

To assess the relevance of the approach with clusters of practices, we used a hierarchical analysis. A mixed-effect Cox model was used to estimate the influence of the clusters on the center effect for the two events: technique failure, and first peritonitis episode. An empty Cox model (model 0) with center as random effect was fitted to estimate the random effect. Individual characteristics (level 1 covariates) were included in the model (model 1) to investigate whether the heterogeneity between centers was explained by the patient composition of the center. Cluster (level 2 covariates) was included in the model (model 2) to determine the magnitude of the clusters on the center effect. Model 1 and model 2 were compared with model 0 by analysis of variance (ANOVA). The proportional change in variance was calculated to estimate the contribution of the covariates in each model. Individual characteristics (level 1 covariates) were entered a priori in the multivariate analysis to improve the assessment of the center effect.

### Validation analysis {#sec017}

We performed Cox and Fine and Gray analysis for each practice at the patients' level to assess the isolated effect of practices on technique failure risk. Results were compared with those found in the 4^th^ cluster of centers.

The rate of missing data was \< 3%. Given this very low rate, a complete case analysis was performed.

Statistical analyses were performed with R 3.1.1 (R Foundation for Statistical Computing, Vienna, Austria) including the hclust, survival, cmprsk and coxme packages.

The RDPLF provides an informative note to the patients, explaining the use made of their data, their rights to get an access to these data. Patients are informed of their right to oppose to the collection of their data without any consequence on their treatment. Nephrologists in the centers participating to the registry have the responsibility to give this note to any included patient, to obtain the patient's signature for agreement, and to keep this agreement in the medical records. The RDPLF has the approval of the French National Ethics Committee (*Commission nationale de l'informatique et des libertés*, *agreement number 542 668*) and fulfills the GDPR requests). This study took place within the framework of this authorization. All data analyzed were fully anonymized by the RDPLF, before we accessed them.

This study was reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines \[[@pone.0218677.ref017]\].

Results {#sec018}
=======

Patient characteristics (level 1 covariates) {#sec019}
--------------------------------------------

Data concerning 2727 PD catheters placed in 2540 patients were included from 64 centers ([Fig 1](#pone.0218677.g001){ref-type="fig"}). The proportion of men was 1661/2727 (61%), median age was 68 years (first and third quartiles, 54 and 80), and median weight was 70.5 kg (first and third quartiles, 61 and 82). Of the 2727 patients 878 (35%) were diabetic.

![Flowchart.](pone.0218677.g001){#pone.0218677.g001}

Center characteristics and clusters of practices (level 2 covariates) {#sec020}
---------------------------------------------------------------------

There were 10 academic hospitals, 33 community hospitals, 12 nonprofit centers, and 9 private centers ([Fig 2](#pone.0218677.g002){ref-type="fig"}). The number of catheters placed and listed in each center ranged from 5 to 132 (median = 34, first and third quartiles = 15--61). No collinearity was detected between the practices with generalized variance index factors \< 5.

![Type of administrative structures.](pone.0218677.g002){#pone.0218677.g002}

Five clusters of centers have been identified, according to the similarity of their PD catheter related practices ([Fig 3](#pone.0218677.g003){ref-type="fig"}). [Table 1](#pone.0218677.t001){ref-type="table"} describes the distribution of patient characteristics among the five clusters of centers. Center characteristics and their distribution among the five clusters are given in [Table 2](#pone.0218677.t002){ref-type="table"} and illustrated in [Fig 4](#pone.0218677.g004){ref-type="fig"}.

10.1371/journal.pone.0218677.t001

###### Distribution of patient-level characteristics in the five clusters of centers.

![](pone.0218677.t001){#pone.0218677.t001g}

                                             Cluster 1     Cluster 2     Cluster 3     Cluster 4     Cluster 5
  ------------------------- ---------------- ------------- ------------- ------------- ------------- -------------
  Patient characteristics                                                                            
  Sex: male (%)                              427 (61)      197 (65)      538 (58)      336 (64)      163 (61)
  Weight in kg              Median (IQR)     71 (62--82)   75 (62--86)   70 (60--80)   72 (63--84)   67 (59--77)
  Obesity: N (%)                             80 (11)       38 (12)       93 (10)       102 (19)      14 (5)
  Malnutrition: N (%)                        79 (11)       32 (11)       44 (5)        104 (20)      18 (7)
  Age at PD initiation      Median (IQR)     71 (58--81)   66 (54--78)   65 (51--79)   73 (59--81)   67 (52--78)
  Nephropathy: N (%)        Diabetic         156 (22)      55 (18)       187 (20)      94 (18)       31 (12)(38)
                            GN               66 (9)        30 (10)       83 (9)        55 (10)       26 (10)
                            Unknown          67 (10)       30 (10)       78 (8)        46 (9)        47 (18)
                            TIN              31 (4)        16 (5)        35 (4)        21 (4)        15 (6)
                            ADPKD            34 (5)        21 (7)        73 (8)        29 (5)        28 (10)
                            Urologic         3 (0)         4 (1)         16 (2)        29 (5)        1 (0)
                            Vascular         95 (14)       10 (3)        91 (10)       68 (13)       17 (6)
                            Other            249 (36)      138 (45)      364 (39)      208 (39)      102 (38)
  Diabetes: N (%)           Oral treatment   37 (5)        23 (8)        39 (4)        23 (4)        11 (5)
                            Insulin          194 (30)      98 (29)       264 (29)      161 (31)      66 (21)
                            Diet             22 (3)        12 (4)        35 (4)        25 (5)        14 (5)
  Modified CCI              Median (IQR)     4 (2--5)      3 (2--5)      3 (2--5)      4 (2--5)      3 (2--5)

N: Number; IQR: Interquartile range; PD: Peritoneal Dialysis; GN: Glomerulonephritis; TIN: Tubulo interstitial nephropathy. ADPKD: Autosomic dominant polycystic kidney disease. IP: Intra peritoneal. SC: Sub cutaneous. CCI: Charlson Comorbidity Index

10.1371/journal.pone.0218677.t002

###### Distribution of center-level characteristics in the five clusters of centers.

![](pone.0218677.t002){#pone.0218677.t002g}

                                                                                Cluster 1     Cluster 2      Cluster 3     Cluster 4     Cluster 5
  ------------------------------------------------------ ---------------------- ------------- -------------- ------------- ------------- -------------
  Administrative structure                               Non profit             157 (22)      124 (41)       238 (26)      63 (12)       71 (27)
                                                         Community hosp.        432 (62)      12 (4)         427 (46)      462 (88)      33 (12)
                                                         Academic hosp.         32 (5)        168 (55)       222 (24)      3 (1)         73 (27)
                                                         Private                80 (11)       0              38 (4)        0             90 (34)
  Catheters registered                                   Median (IQR)           22 (14--41)   84 (39--121)   51 (37--70)   24 (12--61)   26 (18--63)
  Surgical technique for catheter placement              Laparoscopy            292 (42)      16 (5)         349 (38)      67 (13)       65 (24)
                                                         Open surgery           403 (57)      287 (94)       573 (62)      456 (86)      202 (76)
                                                         Trocart                6 (1)         1 (0)          5 (1)         5 (1)         0
  Specialized surgeon                                                           662 (94)      213 (70)       884 (95)      507 (96)      250 (94)
  Catheter type                                          Swan neck---straight   374 (53)      52 (17)        394 (43)      91 (17)       85 (32)
                                                         Swan neck---coiled     164 (23)      195 (64)       59 (6)        65 (12)       56 (21)
                                                         Straight---straight    81 (12)       7 (2)          329 (35)      240 (45)      42 (16)
                                                         Straight---coiled      80 (11)       50 (16)        142 (15)      131 (25)      81 (30)
                                                         Other                  2 (0)         0              3 (0)         1 (0)         3 (1)
  Prophylactic antibiotics prior to catheter placement   Vancomycin             118 (17)      20 (7)         296 (32)      2 (0)         19 (7)
                                                         Other antibiotics      231 (33)      152 (50)       215 (23)      161 (30)      141 (53)
                                                         No antibiotic          334 (48)      116 (38)       376 (41)      355 (67)      104 (39)
                                                         Unknown                18 (3)        16 (5)         40 (4)        10 (2)        3 (1)
  Nasal S. aureus screening                              Not screened           465 (66)      252 (83)       451 (49)      455 (86)      132 (49)
                                                         Positive test          41 (6)        4 (1)          111 (12)      6 (1)         8 (21)
                                                         Negative test          195 (28)      48 (16)        365 (39)      67 (13)       114 (43)
  Nasal prophylactic antibiotics                         No                     669 (95)      292 (96)       861 (93)      506 (96)      258 (97)
                                                         Mupirocine             14 (2)        3 (1)          46 (5)        5 (1)         5 (2)
                                                         Other antibiotics      5 (1)         0              5 (1)         2 (0)         1 (0)
                                                         Unknown                13 (2)        9 (3)          15 (2)        15 (3)        3 (1)
  Local prophylactic antibiotics on exit-site            No                     556 (79)      292 (96)       743 (80)      368 (70)      217 (81)
                                                         Mupirocine             130 (19)      3 (1)          154 (17)      144 (27)      41 (15)
                                                         Other antibiotics      2 (0)         1 (0)          13 (1)        2 (0)         6 (2)
                                                         Unknown                13 (2)        8 (3)          17 (2)        14 (3)        3 (1)
  Delay for first dressing                               0 to 5 days            370 (53)      79 (26)        217 (23)      201 (38)      64 (24)
                                                         6 to 15 days           328 (47)      224 (74)       706 (76)      325 (62)      203 (76)
                                                         After day 16           3 (0)         1 (0)          4 (0)         2 (0)         0
  Antiseptic used for dressing                           No antiseptic          31 (4)        7 (22)         127 (14)      92 (17)       0
                                                         Povidone iodine        6 (1)         89 (29)        29 (3)        40 (8)        107 (40)
                                                         Chlorexidine           331 (47)      138 (45)       531 (57)      298 (56)      40 (15)
                                                         Unknown                333 (48)      55 (18)        240 (26)      98 (19)       120 (45)
  Assistance for PD                                      Family                 40 (6)        9 (3)          65 (7)        22 (4)        17 (6)
                                                         Nurse                  349 (50)      147 (48)       329 (35)      274 (52)      95 (36)
                                                         Patient                306 (44)      137 (45)       508 (55)      228 (43)      147 (55)
                                                         Other assistance       6 (1)         11 (4)         25 (3)        4 (1)         8 (3)
  PD modality                                            APD                    246 (35)      114 (38)       357 (39)      162 (31)      125 (47)
                                                         CAPD                   455 (65)      190 (62)       570 (61)      366 (69)      142 (53)

Hosp: hospital. TAP: Transverse Abdominal Plane. APD: Automated peritoneal dialysis. CAPD: Continuous ambulatory peritoneal dialysis.

![Dendrogram defining the clusters of centers.\
Each PD-center is represented by a black dot at the bottom of the dendrogram, with the number of catheter registered in it. In the virtual space of practices, distances between each center are computed. Centers are joined by nodes placed at a height that is proportional to the distance between the centers. Five clusters of centers are determined to optimize the variability between clusters while minimizing complexity.](pone.0218677.g003){#pone.0218677.g003}

![Distribution of practices in the five clusters of centers.\
The distribution of the modalities used for each practices is represented in the five clusters of centers. Statistically significant differences in the distribution of modalities with cluster 1 (taken as the reference) are marked with a red star.](pone.0218677.g004){#pone.0218677.g004}

Events of interest {#sec021}
------------------

During the follow-up period, there were 604 technique failures, 755 peritonitis episodes occurring in 675 patients, and 81 cases of technique failure due to peritonitis. Survival curves are depicted on [Fig 5](#pone.0218677.g005){ref-type="fig"}.

![Survival Kaplan-Meier curves according to the cluster of centers. 5A. Technique failure. 5B. Peritonitis.](pone.0218677.g005){#pone.0218677.g005}

### Technique failure {#sec022}

The absolute rate of survival free of technique failure censored for transplantation and death was 87% at one year during the follow-up period. In the bivariate analysis, covariates significantly associated with the risk of technique failure were sex, obesity, malnutrition, age, Charlson comorbidity index, and belonging to cluster number 4 in the Cox model, and obesity, malnutrition, age and belonging to cluster 4 in the Fine and Gray model ([Table 3](#pone.0218677.t003){ref-type="table"}). In the multivariate analysis, covariates associated with the risk of technique failure were sex and age in the Cox model. In the Fine and Gray model obesity and age were associated with the risk of technique failure ([Fig 6](#pone.0218677.g006){ref-type="fig"}). Being treated in a PD-unit belonging to the fourth cluster was associated with a lower risk in the Cox model (cause specific-HR = 0.68, 95%CI 0.52--0.88) and in the Fine and Gray model (sub distribution-HR = 0.70, 95%CI 0.54--0.90). Making the distinction between early or late technique failures, we found that the clusters of centers were not associated with different risks of early technique failure ([S1 Table](#pone.0218677.s001){ref-type="supplementary-material"} and [S2 Fig](#pone.0218677.s005){ref-type="supplementary-material"}). On the other side, cluster 4 was protective against the risk of late technique failure (sub distribution-HR 0.62; 95%CI 0.46--0.85) ([S1 Table](#pone.0218677.s001){ref-type="supplementary-material"} and [S4 Fig](#pone.0218677.s007){ref-type="supplementary-material"}). The results of the bivariate analysis concerning the composite outcome of technique failure and mortality are shown in [S2 Table](#pone.0218677.s002){ref-type="supplementary-material"}. Cluster 4 was still protective in the multivariate analysis, with the Cox model (cause specific-HR 0.80; 95%CI 0.67--0.95), and the Fine and Gray model (subdistribution-HR 0.81; 95%CI 0.68--0.96) ([S4 Fig](#pone.0218677.s007){ref-type="supplementary-material"}).

10.1371/journal.pone.0218677.t003

###### Bivariate analysis for the three events of interest.

Results of the Cox and Fine and Gray models.

![](pone.0218677.t003){#pone.0218677.t003g}

                     Technique failure                                          Peritonitis                                                Technique Failure due to peritonitis                                                                                  
  ------------------ ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  **Covariates**                                                                                                                                                                                                                                                 
  **Sex (Male)**     1.16 (0.99--1.37)[\*](#t003fn002){ref-type="table-fn"}     1.09 (0.93--1.08)                                          1.10 (0.95--1.28)[\*](#t003fn002){ref-type="table-fn"}     1.06 (0.88--1.28)                                          1.75 (1.07--2.85)[\*\*](#t003fn003){ref-type="table-fn"}
  **Obesity**        1.16 (0.92--1.46)[\*](#t003fn002){ref-type="table-fn"}     1.21 (0.97--1.52)[\*](#t003fn002){ref-type="table-fn"}     1.59 (1.31--1.93)[\*\*](#t003fn003){ref-type="table-fn"}   1.70 (1.33--2.17)[\*\*](#t003fn003){ref-type="table-fn"}   0.47 (0.19--1.15)[\*](#t003fn002){ref-type="table-fn"}
  **Malnutrition**   0.81 (0.60--1.1)[\*](#t003fn002){ref-type="table-fn"}      0.70 (0.52--0.95)[\*\*](#t003fn003){ref-type="table-fn"}   0.95 (0.74--1.20)                                          1.34 (1.02--1.77)[\*\*](#t003fn003){ref-type="table-fn"}   0.47 (0.17--1.29)[\*](#t003fn002){ref-type="table-fn"}
  **Age**            P \< 0.001[\*\*](#t003fn003){ref-type="table-fn"}          P \< 0.001[\*\*](#t003fn003){ref-type="table-fn"}          P = 0.03[\*\*](#t003fn003){ref-type="table-fn"}            P \< 0.001[\*\*](#t003fn003){ref-type="table-fn"}          P = 0.22
  **18--39**         Ref.                                                       Ref.                                                       Ref.                                                       Ref.                                                       Ref.
  **40--59**         0.93 (0.71--1.22)                                          1.03 (0.79--1.34)                                          0.75 (0.59--0.97)[\*\*](#t003fn003){ref-type="table-fn"}   1.02 (0.67--1.57)                                          2.04 (0.84--4.92)[\*](#t003fn002){ref-type="table-fn"}
  **60--79**         0.71 (0.55--0.91)[\*\*](#t003fn003){ref-type="table-fn"}   0.80 (0.62--1.03)[\*](#t003fn002){ref-type="table-fn"}     0.75 (0.59--0.94)[\*](#t003fn002){ref-type="table-fn"}     1.65 (1.13--2.43)[\*\*](#t003fn003){ref-type="table-fn"}   1.50 (0.63--3.54)
  **\> 80**          0.58 (0.44--0.78)[\*\*](#t003fn003){ref-type="table-fn"}   0.58 (0.43--0.78)[\*\*](#t003fn003){ref-type="table-fn"}   0.68 (0.53--0.88)[\*\*](#t003fn003){ref-type="table-fn"}   2.21 (1.49--3.27)[\*\*](#t003fn003){ref-type="table-fn"}   0.91 (0.35--2.37)
  **Diabetes**       1.10 (0.93--1.29)                                          1.07 (0.91--1.27)                                          1.08 (0.93--1.25)                                          1.33 (1.10--1.61)[\*\*](#t003fn003){ref-type="table-fn"}   0.92 (0.58--1.46)
  **Nephropathy**    P = 0.29                                                   P = 0.39                                                   P = 0.28                                                   P = 0.01[\*](#t003fn002){ref-type="table-fn"}              P = 0.36
  **Diabetic**       Ref.                                                       Ref.                                                       Ref.                                                       Ref.                                                       Ref.
  **GN**             0.90 (0.66--1.21)                                          0.91 (0.67--1.23)                                          0.79 (0.59--1.05)[\*](#t003fn002){ref-type="table-fn"}     0.54 (0.36--0.82)[\*\*](#t003fn003){ref-type="table-fn"}   1.97 (0.86--4.54)[\*](#t003fn002){ref-type="table-fn"}
  **Unknown**        0.86 (0.64--1.17)                                          0.85 (0.63--1.16)                                          0.74 (0.55--0.99)[\*\*](#t003fn003){ref-type="table-fn"}   0.77 (0.54--1.11)[\*](#t003fn002){ref-type="table-fn"}     1.20 (0.47--3.09)
  **TIN**            0.76 (0.50--1.16)                                          0.78 (0.51--1.19)                                          1.11 (0.78--1.57)                                          0.79 (0.49--1.29)                                          2.76 (1.08--7.03)[\*\*](#t003fn003){ref-type="table-fn"}
  **ADPKD**          0.82 (0.58--1.15)                                          0.80 (0.57--1.10)[\*](#t003fn002){ref-type="table-fn"}     0.93 (0.69--1.27)                                          0.44 (0.27--0.73)[\*\*](#t003fn003){ref-type="table-fn"}   1.67 (0.65--4.33)
  **Urologic**       0.81 (0.40--1.66)                                          0.87 (0.42--1.79)                                          0.61 (0.29--1.30)                                          0.57 (0.22--1.47)                                          1.32 (0.17--10.28)
  **Vascular**       0.64 (0.47--0.88)[\*\*](#t003fn003){ref-type="table-fn"}   0.68 (0.50--0.94)[\*](#t003fn002){ref-type="table-fn"}     0.85 (0.64--1.12)                                          0.91 (0.65--1.27)                                          0.81 (0.28--2.32)
  **Other**          0.85 (0.69--1.05)[\*](#t003fn002){ref-type="table-fn"}     0.81 (0.65--0.99)[\*\*](#t003fn003){ref-type="table-fn"}   0.89 (0.73--1.09)                                          0.86 (0.67--1.10)                                          1.42 (0.72--2.81)
  **Modified CCI**   P = 0.15[\*](#t003fn002){ref-type="table-fn"}              P = 0.32                                                   P = 0.93                                                   P \< 0.001[\*\*](#t003fn003){ref-type="table-fn"}          P = 0.79
  **2--3**           Ref.                                                       Ref.                                                       Ref.                                                       Ref.                                                       Ref.
  **4--5**           0.88 (0.73--1.06)[\*](#t003fn002){ref-type="table-fn"}     0.87 (0.73--1.05)[\*](#t003fn002){ref-type="table-fn"}     1.03 (0.88--1.22)                                          1.51 (1.23--1.86)[\*\*](#t003fn003){ref-type="table-fn"}   0.84 (0.50--1.40)
  **5--16**          1.10 (0.90--1.36)                                          1.00 (0.81--1.23)                                          1.00 (0.83--1.22)                                          1.48 (1.16--1.90)[\*\*](#t003fn003){ref-type="table-fn"}   0.97 (0.55--1.73)
  **Cluster**        P = 0.005[\*\*](#t003fn003){ref-type="table-fn"}           P = 0.04[\*\*](#t003fn003){ref-type="table-fn"}            P = 0.17                                                   P = 0.01                                                   P = 0.003[\*\*](#t003fn003){ref-type="table-fn"}
  **Cluster 1**      Ref.                                                       Ref.                                                       Ref.                                                       Ref.                                                       Ref.
  **Cluster 2**      1.05 (0.80--1.37)                                          1.03 (0.79--1.34)                                          1.11 (0.88--1.42)                                          0.95 (0.69--1.31)                                          2.51 (1.30--4.84)[\*\*](#t003fn003){ref-type="table-fn"}
  **Cluster 3**      1.00 (0.82--1.24)                                          1.00 (0.81--1.22)                                          0.85 (0.70--1.03)                                          0.78 (0.61--1.00)[\*](#t003fn002){ref-type="table-fn"}     1.32 (0.72--2.41)
  **Cluster 4**      0.67 (0.51--0.86)                                          0.70 (0.54--0.90)[\*\*](#t003fn003){ref-type="table-fn"}   1.00 (0.81--1.24)                                          1.20 (0.92--1.56)[\*](#t003fn002){ref-type="table-fn"}     0.46 (0.18--1.17)
  **Cluster 5**      0.98 (0.74--1.32)                                          1.00 (0.75--1.33)                                          0.94 (0.72--1.23)                                          0.74 (0.51--1.08)[\*](#t003fn002){ref-type="table-fn"}     1.36 (0.60--3.09)

Cs-HR: Cause specific hazard ratio; sd-HR: sub distribution hazard ratio; p: global p-value; GN: Glomerulonephritis; CCI: Charlson comorbidity index; PD: peritoneal dialysis;

\*: p \< 0.2;

\*\*: p \< 0.05

![Association between covariates and technique failure. Results of the multivariate Cox model (A) and Fine and Gray model (B).\
The class of references are: female for the sex, 18--39 years old for the age, 2--3 for the modified Charlson comorbidity index, and cluster number 1 for the clusters of centers. CCI: modified Charlson Comorbidity Index, cs-HR: cause specific hazard-ratio, 95%CI: 95% confidence interval, sd-HR: subdistribution specific hazard-ratio.](pone.0218677.g006){#pone.0218677.g006}

### Peritonitis {#sec023}

Of the 755 first episodes of peritonitis, 348 were due to Gram-positive cocci, 188 to Gram-negative bacilli, 18 to Gram-positive bacilli, 6 to fungi, and 195 to unidentified organism. The results of the bivariate analysis are given in [Table 3](#pone.0218677.t003){ref-type="table"}. In the Cox multivariate analysis, there was no significant difference between the five clusters for the peritonitis risk neither in the Cox nor in the Fine and Gray model ([S5 Fig](#pone.0218677.s008){ref-type="supplementary-material"}).

### Technique failure due to peritonitis {#sec024}

Taking into account the competing events with a Fine and Gray model, cluster 2 was associated with a greater risk of technique failure due to peritonitis in the bivariate analysis ([Table 3](#pone.0218677.t003){ref-type="table"}) as in the multivariate analysis (sub distribution-HR 2.48, 95%CI 1.29--4.78) ([S6 Fig](#pone.0218677.s009){ref-type="supplementary-material"}).

Hierarchical modeling {#sec025}
---------------------

Considering technique failure, the SD of the random effect was 0.31 in model 0. This indicates that before any adjustments, the patients treated in centers with a random effect greater than 1 SD above the mean had a relative risk of technique failure higher than 1.36 (exponential of 0.31). The variance of the random effect decreased by 5% after adjusting for patient characteristics and by 26% after adjusting for patient characteristics and center clusters. Model 1 and model 2 were significantly different from model 0 according to ANOVA (p = 3·10^−3^ and p = 2·10^−3^, respectively). These results suggest that the clusters of practices explained a fifth of the center effect. Being treated in the fourth cluster was associated with a lower risk of technique failure (cause specific-HR 0.70, 95%CI 0.50--1.00) ([Table 4](#pone.0218677.t004){ref-type="table"}).

10.1371/journal.pone.0218677.t004

###### Hierarchical analysis for the primary outcome: Technique failure (multivariate analysis with a mixed effect Cox model).

![](pone.0218677.t004){#pone.0218677.t004g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                        Model 0\      Model 1\                                                 Model 2\
                                                        Empty model   cs-HR (95%CI)                                            cs-HR (95%CI)
  ----------------------------------------------------- ------------- -------------------------------------------------------- --------------------------------------------------------
  Level 1 covariate                                                                                                            

  Sex: Male                                             \-            1.19 (1.00--1.41)[\*](#t004fn002){ref-type="table-fn"}   1.19 (1.01--1.42)[\*](#t004fn002){ref-type="table-fn"}

  Obesity                                               \-            1.23 (0.96--1.58)                                        1.25 (0.97--1.60)

  Malnutrition                                          \-            1.02 (0.74--1.40)                                        1.03 (0.75--1.43)

  Age at PD initiation                                  \-                                                                     

  18--39                                                              Ref.                                                     Ref.

  40--59                                                              0.95 (0.72--1.26)                                        0.96 (0.73--1.28)

  60--79                                                              0.67 (0.5--0.89)[\*](#t004fn002){ref-type="table-fn"}    0.68 (0.51--0.91)[\*](#t004fn002){ref-type="table-fn"}

  \>80                                                                0.60 (0.43--0.82)[\*](#t004fn002){ref-type="table-fn"}   0.60 (0.44--0.83)[\*](#t004fn002){ref-type="table-fn"}

  Nephropathy                                                                                                                  

  Diabetic                                                            Ref.                                                     Ref.

  GN                                                                  0.79 (0.55--1.15)                                        0.80 (0.55--1.16)

  Unknown                                                             0.84 (0.58--1.23)                                        0.84 (0.58--1.23)

  TIN                                                                 0.69 (0.43--1.12)                                        0.69 (0.43--1.12)

  ADPKD                                                               0.74 (0.48--1.13)                                        0.74 (0.48--1.13)

  Urologic                                                            0.82 (0.38--1.79)                                        0.82 (0.38--1.78)

  Vascular                                                            0.73 (0.50--1.06)                                        0.74 (0.51--1.07)

  Other                                                               0.79 (0.59--1.06)                                        0.79 (0.59--1.06)

  Diabetes                                              \-            1.02 (0.78--1.33)                                        1.02 (0.78--1.33)

  Modified CCI                                                                                                                 

  2--3                                                  \-            Ref.                                                     Ref.

  4--5                                                                0.93 (0.75--1.16)                                        0.93 (0.75--1.16)

  \>5                                                                 1.07 (0.82--1.41)                                        1.06 (0.81--1.4)

  Level 2 covariates                                    \-                                                                     

  Cluster                                                                                                                      

  Cluster 1                                             \-            \-                                                       Ref.

  Cluster 2                                                                                                                    1.10 (0.72--1.68)

  Cluster 3                                                                                                                    1.07 (0.80--1.43)

  Cluster 4                                                                                                                    0.70 (0.50--1.00)[\*](#t004fn002){ref-type="table-fn"}

  Cluster 5                                                                                                                    1.00 (0.67--1.50)

  Random effect                                                                                                                

  Standard error (variance)                             0.31 (0.1)    0.3 (0.09)                                               0.27 (0.07)

  Standard error of the variance of the random effect   0--0.45       0--0.45                                                  0--0.86

  p-value (ANOVA)                                       \-            0.003[\*](#t004fn002){ref-type="table-fn"}               0.002[\*](#t004fn002){ref-type="table-fn"}

  PCV (%)                                               \-            5                                                        26
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PD: Peritoneal Dialysis; GN: Glomerulonephritis; TIN: Tubulo interstitial nephropathy. ADPKD: Autosomic dominant polycystic kidney disease. CCI: Charlson Comorbidity Index. ICC: Intraclass correlation coefficient. ANOVA: analysis of variance. PCV: Proportional change in variance.

\*: p\<0.05

Differences of practices between the clusters {#sec026}
---------------------------------------------

Compared with the first cluster, which was the reference, we found out that cluster 4 was protective against technique failure (cause specific-HR 0.68, 95%CI 0.52--0.88). In the centers from this cluster, there was a greater proportion of community hospitals, open surgery catheter placements, coiled catheters placed, use of local prophylactic antibiotics on exit-site, antiseptic use for dressing, and first dressing after catheter placement made between 5 and 14 days. On the other hand, there was fewer use of prophylactic antibiotic prior to catheter placement, and screening for nasal S. aureus presence. There was no difference on the covariates: use of assistance, PD modality, specialized surgeon for catheter placement ([S5 Fig](#pone.0218677.s008){ref-type="supplementary-material"}).

Validation {#sec027}
----------

Results of the bivariate Cox and Fine and Gray models at the patient's level are shown in [S3 Table](#pone.0218677.s003){ref-type="supplementary-material"}. In the competing risk analysis, several practices were protective against the risk of technique failure at the patient's level: being treated in a community hospital compared to being treated in an academic hospital (sub distribution -HR 1.25, 95%CI 1.02--1.54), or a private center (sub distribution -HR 1.42, 95%CI 1.09--1.87), open surgery for catheter placement compared with laparoscopy (sub distribution -HR 0.78, 95%CI 0.49--0.92), and use of local prophylactic antibiotic on exit-site (sub distribution -HR 0.65, 95%CI 0.51--0.82). This is consistent with the practices of cluster 4, found to be protective against the risk of technique failure in the hierarchical analysis. Use of assistance for PD exchange was protective at the patient's level (sub distribution -HR 0.68, 95%CI 0.58--0.80), whereas there was no significant difference in the clusters analysis. Practices with a greater risk for technique failure were use of APD (sub distribution -HR 1.34, 95%CI 1.15--1.57), and use of antiseptic for dressing (sub distribution -HR 1.66, 95%CI 1.19--2.31). Eventually, there was no difference according to the type of PD catheter used, delay for first dressing, prophylactic antibiotic use prior to catheter placement, nasal screening for *S*. *aureus*, and surgeon experience.

Discussion {#sec028}
==========

Using an ascendant hierarchical analysis, we defined five clusters of centers with similar patterns of PD catheter related practices \[[@pone.0218677.ref010]\]. Our study shows that the risk of technique failure and the risk of technique failure due to peritonitis were different in these five clusters. In the hierarchical analysis, the belonging to a given cluster explained partly the center effect associated with the risk of technique failure, as the variance of the random effect decreased by 26% after adjusting for both patient characteristics and center clusters.

One should wonder why clusters of centers were used instead of studying the effect of each given practice separately. Randomized trials are mandatory to determine the best practices to propose to PD patients, but unfortunately, due to the large numbers of eligible practices, it is unlikely that evidence will be produced for each practice. Moreover, interactions may exist between practices and may have a synergic effect on the outcomes. The cluster analysis could help to identify association of practices that could influence positively the patient outcome. Furthermore, the method of clustering centers could allow implementation of quality improvement programs in group of centers, to prioritize the action at a nationwide level especially when practices are modifiable.

Cluster identification could also lead to research about the effect of pattern of practices on the patient outcome. In support of this, in the pattern of practices of cluster 4, a greater proportion of patients received local prophylactic antibiotics on exit-site, a finding in line with the ISPD guidelines, \[[@pone.0218677.ref011]\]. In the PanThames study, the effect of local prophylactic antibiotic use on exit-site has been assessed in twelve English PD-units in 2012. Neither mupirocin nor gentamycin reduced the peritonitis rate \[Panthames\]. In the cluster 4, there were more catheters placed via open surgery, and the delay for first dressing refection was between 6 to 15 days after surgery. These 2 practices have not shown their superiority in previous study to our knowledge. On the other hand, more patients in this cluster did not receive prophylactic antibiotic prior to catheter placement, whereas this practice is known to be protective against the peritonitis risk \[[@pone.0218677.ref018]\].

We found that cluster 4 was protective against the risk of late technique failure, whereas there was no association with the risk of early technique failure. We can hypothesize from these results that the protective effect observed in cluster 4 was mainly due to the use of local prophylactic antibiotics on exit-site, the absence of antiseptic use for dressing, and the absence of screening for nasal *S*. *aureus*, which have a sustained effect in time.

Substantial variations in the peritonitis rate are reported between countries but also within countries \[[@pone.0218677.ref019]\]\[[@pone.0218677.ref011]\]. On the one hand, identifying clusters of centers with similar practices and poorer outcomes allows for a focus on centers with room for improvement because practices are modifiable. On the other hand, this method could identify units where outcomes are less favorable because of the patient characteristics.

Early peritonitis was associated with worse technique survival (HR 0.54, 95%CI 0.30--0.98) in a 10-year single-center study in Taiwan \[[@pone.0218677.ref001]\]. In another retrospective single-center study from China, peritonitis occurring in the first 6 months after starting PD was an independent risk factor for technique failure (HR 1.69, 95%CI 1.12--2.87) \[[@pone.0218677.ref020]\]. See et al. used the ANZDATA registry in a large observational study to describe the predictors and outcomes of early peritonitis. Among 3827 registered episodes of early peritonitis, 628 (16%) were followed by technique failure \[[@pone.0218677.ref004]\]. Other observational studies have tried to elucidate risk factors for peritonitis and poor outcomes \[[@pone.0218677.ref005]\] \[[@pone.0218677.ref021]\]. In all these studies, patient characteristics were very nearly the only variable tested, and few modifiable center-level characteristics were integrated in the analysis. However, evidence has emerged that the peritonitis risk in PD is associated with modifiable center-specific characteristics \[[@pone.0218677.ref008]\] \[[@pone.0218677.ref022]\].

Few studies have focused on PD outcomes related to center-level characteristics. In a retrospective study analyzing 9100 episodes of peritonitis from the ANZDATA registry, Htay et al. showed that center-level characteristics substantially influenced PD peritonitis outcomes. Centers with more than 29% of dialysis patients treated with PD had higher odds of cured peritonitis (odds ratio (OR) 1.21, 95%CI 1.04--1.40) and lower odds of catheter removal (OR 0.78, 95%CI 0.62--0.97), transfer to hemodialysis therapy (OR 78, 95%CI 0.62--0.97) and peritonitis relapse/recurrence (OR 0.68, 95%CI 0.48--0.98) \[[@pone.0218677.ref023]\]. In another retrospective multicentric study from the same team, 5813 episodes of technique failure were observed in 9642 incident patients on PD during a 10-year follow-up period. The cause of technique failure was infection in 1577 (27%) cases. Variation in the hazards of technique failure across centers was reduced by 28% after adjusting for patient-level characteristics and by an additional 53% after adjusting for center-level characteristics \[[@pone.0218677.ref024]\]. Guillouet et al. from our team determined in a previous study from the RDPLF data that centers characteristics accounted for 52% of the variations in early PD failure and that center size was associated with the risk of early PD failure \[[@pone.0218677.ref009]\].

Peritonitis risk was not different between the five clusters. However, cluster 2 was associated with a greater risk of technique failure due to peritonitis. This reflects that peritonitis outcomes are not uniform between the centers. Htay et al. found that the variation in odds of peritonitis cure across Australian centers was 66% lower after adjustment for center-level characteristics \[[@pone.0218677.ref023]\]. Ways of treating peritonitis could be dissimilar, or transfer to hemodialysis could be considered earlier in some centers.

Taken together, these results argue that center experience and practices are more important than patient characteristics in determining major clinical outcomes in PD, such as technique failure and peritonitis outcome.

Quality improvement programs have already proven their efficacy in PD care. The overall rate of technique failure was significantly reduced in Australia and New Zealand after a 2009 national peritonitis prevention program \[[@pone.0218677.ref025]\]. Poor adherence to international guidelines was outlined in different countries \[[@pone.0218677.ref010]\] \[[@pone.0218677.ref012]\]. Implementation of changes in patient care is known to be arduous. Various strategies should be used to put guidelines into practice, such as educational interactive small group meetings, use of local opinion leaders and reminders, computerized decision support, financial intervention, performance feedback, and patient-mediated intervention \[[@pone.0218677.ref026]\]. It would be of interest to know whether a post-peritonitis re-training protocol exists in the PD-units, as advised by the ISPD \[[@pone.0218677.ref011]\].

Considering every practice of a PD unit and assessing the coherence of the whole program could be a further step toward improvement. The "clusters method" that we propose here does not give a definitive answer to what the more suitable practices are, but it adds significant information by identifying centers where poor outcomes should be more prone to improve, by evaluating and changing practices.

To our knowledge, this study is the first to propose a comparison of clinical outcomes among clusters of centers with similar practices. A large population of incident PD patients was included with very good quality data \[[@pone.0218677.ref014]\]. Robust statistical methodologies were used, allowing for an assessment of the adjustment of patient- and center-level characteristics and competing risks.

However, these strengths should be balanced against the study's limitations, including the retrospective design and possibility of reporting bias. The use of registry data restricts the availability of clinical variables. Participation in the registry is voluntary, thus centers participating in the RDPLF may have more involvement in PD than other centers and may have different practices. Covariates declared in the registry, like specialization of the surgeon, were not defined in a standardized way, exposing to a declaration bias. The survival models used here do not allow handling for multiple events, which is a limitation considering the outcome peritonitis.

In conclusion, clusters of centers with similar patterns of practices can be identified in France. These patterns of practices are associated with significantly different risks of technique failure. Belonging to a given cluster explained a significant part of the center effect associated with the risk of technique failure, and therefore combinations of profitable practices are suggested.

Supporting information {#sec029}
======================

###### Early and late technique failure. Bivariate Cox and Fine and Gray analyses.

Early technique failure is defining as occurring earlier than 3 months after the starting of PD. Late technique failure is defining as occurring later than 3 months after the starting of PD. Cs-HR: Cause specific hazard ratio; sd-HR: sub distribution hazard ratio; p: global p-value; GN: Glomerulonephritis; TIN: tubulointertitial nephritis; ADPKD: autosomic dominant polycystic disease; CCI: Charlson comorbidity index, \*: p \< 0.2; \*\*: p \< 0.05.

(DOCX)

###### 

Click here for additional data file.

###### Composite outcome of technique failure and mortality bivariate Cox and Fine and Gray analyses.

Cs-HR: Cause specific hazard ratio; sd-HR: sub distribution hazard ratio; GN: Glomerulonephritis; TIN: tubulointertitial nephritis; ADPKD: autosomic dominant polycystic disease; CCI: Charlson comorbidity index, \*: p \< 0.2; \*\*: p \< 0.05.

(DOCX)

###### 

Click here for additional data file.

###### Validation analysis. Bivariate Cox and Fine and Gray analysis for technique failure according to practices.

Hosp: hospital, CAPD: Continuous Ambulatory Peritoneal Dialysis. APD: Automated Peritoneal Dialysis. \*: p-value \< 0.05.

(DOCX)

###### 

Click here for additional data file.

###### Geometrical representation of a centre in the three-dimensional geographic space (A), and in the virtual space of practices (B).

In the geographical space, the dimensions are e~X~, e~Y~, and e~Z~, corresponding to the longitude, latitude and altitude. In the space of practices, e~1~ may be the use of prophylactic antibiotic prior to catheter insertion, e~2~ the type of catheter placed in the center, and each e~i~ a given practice. In this space of n-dimension, a metric is built and distances between centers are computed, allowing to gathering the centers according to their proximity in term of practice.

(TIF)

###### 

Click here for additional data file.

###### Association between covariates and early technique failure (prior to 3 months after the starting of PD). Results of the multivariate Cox model (A), and Fine and Gray model (B).

The classes of references are: female for the sex, 2--3 for the modified Charlson comorbidity index, and cluster number 1 for the clusters of centers. CCI: modified Charlson Comorbidity Index, cs-HR: cause specific hazard-ratio, 95%CI: 95% confidence interval, sd-HR: subdistribution specific hazard-ratio.

(PDF)

###### 

Click here for additional data file.

###### Association between covariates and late technique failure (later than 3 months after the starting of PD). Results of the multivariate Cox model (A), and Fine and Gray model (B).

The classes of references are: diabetic nephropathy for the nephropathy, female for the sex, 18--39 years old for the age, and cluster number 1 for the clusters of centers. GN: glomerulopathy, TIN: tubulo interstitial nephropathy, ADPKD: Autosomic dominant polycystic kidney disease, cs-HR: cause specific hazard-ratio, 95%CI: 95% confidence interval, sd-HR: subdistribution specific hazard-ratio.

(PDF)

###### 

Click here for additional data file.

###### Association between covariates and composite outcome of technique failure and mortality. Results of the multivariate Cox model (A), and Fine and Gray model (B).

The classes of references are: female for the sex, 18--39 years old for the age, diabetic nephropathy for the nephropathy, 2--3 for the modified Charlson comorbidity index, and cluster number 1 for the clusters of centers. GN: glomerulopathy, TIN: tubulo interstitial nephropathy, ADPKD: Autosomic dominant polycystic kidney disease, CCI: modified Charlson Comorbidity Index, cs-HR: cause specific hazard-ratio, 95%CI: 95% confidence interval, sd-HR: subdistribution specific hazard-ratio.

(PDF)

###### 

Click here for additional data file.

###### Association between covariates and peritonitis. Results of the multivariate Cox model (A) and Fine and Gray model (B).

The classes of references are: female for the sex, 18--39 years old for the age, 2--3 for the CCI, and cluster number 1 for the clusters of centers. CCI: modified Charlson Comorbidity Index, cs-HR: cause specific hazard-ratio, 95%CI: 95% confidence interval, sd-HR: subdistribution specific hazard-ratio.

(PDF)

###### 

Click here for additional data file.

###### Association between covariates and technique failure due to peritonitis. Results of the multivariate Fine and Gray model.

The classes of references are cluster number 1 for the clusters of centers. CCI: modified Charlson Comorbidity Index, cs-HR: cause specific hazard-ratio, 95%CI: 95% confidence interval, sd-HR: subdistribution specific hazard-ratio.

(PDF)

###### 

Click here for additional data file.
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